Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walter Mier

Showing results (71-80 of 181) with videos related to

Pageof 19
Sort By:
Organic & Biomolecular Chemistry|March 12, 2013
PEGylation enables the specific tumor accumulation of a peptide identified by phage displayWalter Mier, Susanne Krämer, Sabine Zitzmann, et al.
Plos One|June 14, 2012
Optimization of a novel peptide ligand targeting human carbonic anhydrase IXShoaib Rana, Felix Nissen, Annabell Marr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2005
A new prostate carcinoma binding peptide (DUP-1) for tumor imaging and therapySabine Zitzmann, Walter Mier, Arno Schad, et al.
Bioconjugate Chemistry|February 29, 2012
68Ga-complex lipophilicity and the targeting property of a urea-based PSMA inhibitor for PET imagingMatthias Eder, Martin Schäfer, Ulrike Bauder-Wüst, et al.
Journal of Medicinal Chemistry|February 16, 2016
Linker Modification Strategies To Control the Prostate-Specific Membrane Antigen (PSMA)-Targeting and Pharmacokinetic Properties of DOTA-Conjugated PSMA InhibitorsMartina Benešová, Ulrike Bauder-Wüst, Martin Schäfer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 17, 2007
Identification and evaluation of a new tumor cell-binding peptide, FROP-1Sabine Zitzmann, Susanne Krämer, Walter Mier, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 8, 2018
Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation ProteinThomas Lindner, Anastasia Loktev, Annette Altmann, et al.
Journal of Medicinal Chemistry|January 5, 2007
Polyamine-substituted gadolinium chelates: a new class of intracellular contrast agents for magnetic resonance imaging of tumorsMarkus Wolf, William E Hull, Walter Mier, et al.
International Journal of Antimicrobial Agents|April 13, 2018
A novel tool against multiresistant bacterial pathogens: lipopeptide modification of the natural antimicrobial peptide ranalexin for enhanced antimicrobial activity and improved pharmacokineticsCornelius Domhan, Philipp Uhl, Anna Meinhardt, et al.
Cancer Gene Therapy|May 1, 2004
MIA (melanoma inhibitory activity) promoter mediated tissue-specific suicide gene therapy of malignant melanomaFrank Schoensiegel, Annette Paschen, Stephanie Sieger, et al.
Pageof 19

Showing results (71-80 of 181) with videos related to

Sort By:
Pageof 19
Organic & Biomolecular Chemistry|March 12, 2013
PEGylation enables the specific tumor accumulation of a peptide identified by phage displayWalter Mier, Susanne Krämer, Sabine Zitzmann, et al.
Plos One|June 14, 2012
Optimization of a novel peptide ligand targeting human carbonic anhydrase IXShoaib Rana, Felix Nissen, Annabell Marr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2005
A new prostate carcinoma binding peptide (DUP-1) for tumor imaging and therapySabine Zitzmann, Walter Mier, Arno Schad, et al.
Bioconjugate Chemistry|February 29, 2012
68Ga-complex lipophilicity and the targeting property of a urea-based PSMA inhibitor for PET imagingMatthias Eder, Martin Schäfer, Ulrike Bauder-Wüst, et al.
Journal of Medicinal Chemistry|February 16, 2016
Linker Modification Strategies To Control the Prostate-Specific Membrane Antigen (PSMA)-Targeting and Pharmacokinetic Properties of DOTA-Conjugated PSMA InhibitorsMartina Benešová, Ulrike Bauder-Wüst, Martin Schäfer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 17, 2007
Identification and evaluation of a new tumor cell-binding peptide, FROP-1Sabine Zitzmann, Susanne Krämer, Walter Mier, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 8, 2018
Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation ProteinThomas Lindner, Anastasia Loktev, Annette Altmann, et al.
Journal of Medicinal Chemistry|January 5, 2007
Polyamine-substituted gadolinium chelates: a new class of intracellular contrast agents for magnetic resonance imaging of tumorsMarkus Wolf, William E Hull, Walter Mier, et al.
International Journal of Antimicrobial Agents|April 13, 2018
A novel tool against multiresistant bacterial pathogens: lipopeptide modification of the natural antimicrobial peptide ranalexin for enhanced antimicrobial activity and improved pharmacokineticsCornelius Domhan, Philipp Uhl, Anna Meinhardt, et al.
Cancer Gene Therapy|May 1, 2004
MIA (melanoma inhibitory activity) promoter mediated tissue-specific suicide gene therapy of malignant melanomaFrank Schoensiegel, Annette Paschen, Stephanie Sieger, et al.
Pageof 19